Slide 1 Adverse Events Following Immunization (AEFI) Dr. Vikash Keshri Slide 2 Learning Objectives: Identify common adverse events. How to Prevent Adverse Event From Occurring.…

Slide 1 Fighting a Smarter War On Colon Cancer: John L. Marshall, MD Angiogenesis inhibition through all lines of therapy Tel: (202) 444-0275 Fax: (202) 444-1229 http://lombardi.georgetown.edu/GI…

Slide 1 Randomized Evaluation of Long- term anticoagulant therapY Dabigatran Compared to Warfarin in 18,113 Patients with Atrial Fibrillation at Risk of Stroke Sponsored…

Clinical Review of Protopic Safety, Potential Risk, and Efficacy Martin M. Okun, M.D., Ph.D. Lisa Mathis, M.D. Division of Dermatologic and Dental Drug Products Protopic…

Predictive value of skin-toxicity severity for response to panitumumab in patients with metastatic colorectal cancer (mCRC): a pooled analysis of 5 clinical trials Jordan…

Promotion and Marketing of Prescription Drugs Lesley R. Frank, Ph.D., J.D. FDA-DDMAC September 23, 2004 What is DDMAC? FDAâs Division of Drug Marketing, Advertising, and…

Adverse Events Following Immunization (AEFI) Adverse Events Following Immunization (AEFI) Dr. Vikash Keshri 1 Learning Objectives: Identify common adverse events. How to…

Update on the Side Effects of Tyrosine Kinase Inhibitors Dr Jenny Byrne Nottingham University Hospitals Trust IRIS Study: Most Frequently Reported AEs Only Serious Adverse…

ACHSE 48th Residential Conference March 2002 Leadership and the Quality Challenge - the National Perspective Heather Wellington Member, Australian Council for Safety &…

Change in Systolic BP at Week 24 for Patients Receiving Adjuncts After Week 8 (All Randomized Patients) Change in SBP (mmHg) HCTZ (n = 2476) Other Diuretics (n = 690) Amlodipine…